VIP
LLY icon

Vantage Investment Partners’s Eli Lilly LLY Stock Holding History

Vantage Investment Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.1M Sell
47,894
-3,921
-8% -$3.98M 3.04% 11
2025
Q4 		$55.7M Sell
51,815
-10
-0% -$9.56K 3.72% 7
2025
Q3 		$39.5M Buy
51,825
+2,819
+6% +$2.1M 2.7% 15
2025
Q2 		$38.2M Buy
49,006
+1,363
+3% +$1.06M 2.78% 15
2025
Q1 		$39.3M Buy
47,643
+30,322
+175% +$25.2M 3.31% 8
2024
Q4 		$13.4M Buy
17,321
+943
+6% +$781K 1.17% 27
2024
Q3 		$14.5M Sell
16,378
-1,603
-9% -$1.44M 1.22% 29
2024
Q2 		$16.3M Sell
17,981
-2,505
-12% -$2M 1.48% 18
2024
Q1 		$15.9M Sell
20,486
-9,227
-31% -$6.57M 1.42% 18
2023
Q4 		$17.3M Sell
29,713
-1,401
-5% -$818K 1.73% 19
2023
Q3 		$16.7M Buy
31,114
+656
+2% +$338K 2.19% 16
2023
Q2 		$14.3M Sell
30,458
-11,427
-27% -$4.79M 1.85% 15
2023
Q1 		$14.4M Buy
41,885
+508
+1% +$171K 1.97% 16
2022
Q4 		$15.1M Buy
41,377
+312
+0.8% +$111K 2.35% 13
2022
Q3 		$13.3M Buy
41,065
+112
+0.3% +$35.5K 2.08% 16
2022
Q2 		$13.3M Sell
40,953
-5,341
-12% -$1.6M 1.06% 23
2022
Q1 		$13.3M Buy
46,294
+397
+0.9% +$102K 0.66% 25
2021
Q4 		$12.7M Buy
45,897
+4,164
+10% +$1.06M 0.65% 27
2021
Q3 		$9.64M Sell
41,733
-16,754
-29% -$4.14M 0.5% 29
2021
Q2 		$13.4M Buy
58,487
+12,865
+28% +$2.58M 0.64% 28
2021
Q1 		$8.52M Sell
45,622
-28,716
-39% -$5.62M 0.42% 54
2020
Q4 		$12.6M Sell
74,338
-18,377
-20% -$2.74M 0.73% 24
2020
Q3 		$13.7M Buy
92,715
+2,340
+3% +$362K 0.86% 23
2020
Q2 		$14.8M Buy
90,375
+3,045
+3% +$467K 1.12% 13
2020
Q1 		$12.1M Buy
87,330
+1,544
+2% +$212K 1.05% 14
2019
Q4 		$11.3M Buy
85,786
+130
+0.2% +$15.1K 0.92% 25
2019
Q3 		$9.58M Buy
85,656
+14
+0% +$1.56K 1% 26
2019
Q2 		$9.49M Sell
85,642
-16,034
-16% -$1.89M 1.08% 24
2019
Q1 		$13.2M Buy
101,676
+19
+0% +$2.31K 1.23% 14
2018
Q4 		$11.8M Sell
101,657
-1,495
-1% -$167K 0.84% 21
2018
Q3 		$11.1M Sell
103,152
-6,016
-6% -$601K 0.7% 23
2018
Q2 		$9.31M Sell
109,168
-33,621
-24% -$2.76M 0.67% 32
2018
Q1 		$11M Buy
142,789
+19,513
+16% +$1.57M 0.91% 33
2017
Q4 		$10.4M Sell
123,276
-20,994
-15% -$1.79M 0.95% 42
2017
Q3 		$12.3M Sell
144,270
-4,479
-3% -$367K 0.96% 28
2017
Q2 		$12.2M Buy
148,749
+8,857
+6% +$723K 1.11% 26
2017
Q1 		$11.8M Buy
139,892
+116,752
+505% +$9.35M 1.31% 15
2016
Q4 		$1.7M Sell
23,140
-168,210
-88% -$12.5M 0.23% 42
2016
Q3 		$15.4M Buy
191,350
+6,089
+3% +$487K 1.99% 6
2016
Q2 		$14.6M Buy
185,261
+8,816
+5% +$664K 1.52% 10
2016
Q1 		$12.7M Buy
176,445
+75,170
+74% +$5.69M 1.51% 8
2015
Q4 		$8.53M Sell
101,275
-2,955
-3% -$245K 1.35% 21
2015
Q3 		$8.72M Buy
104,230
+49,840
+92% +$4.21M 1.57% 10
2015
Q2 		$4.54M Buy
54,390
+37,859
+229% +$2.88M 1.25% 14
2015
Q1 		$1.19M Sell
16,531
-40,714
-71% -$2.9M 0.52% 16
2014
Q4 		$3.95M Sell
57,245
-122
-0.2% -$8.23K 1.17% 12
2014
Q3 		$3.72M Sell
57,367
-2,121
-4% -$134K 1.19% 8
2014
Q2 		$3.7M Buy
59,488
+2,479
+4% +$148K 1.08% 11
2014
Q1 		$3.35M Buy
57,009
+5,341
+10% +$298K 1.07% 11
2013
Q4 		$2.63M Buy
51,668
+273
+0.5% +$13.7K 0.86% 22
2013
Q3 		$2.59M Buy
51,395
+209
+0.4% +$10.9K 0.82% 19
2013
Q2 		$2.51M Buy
+51,186
New +$2.79M 0.86% 18

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vantage Investment Partners's LLY Position: Q1 2026 in Review

Vantage Investment Partners reduced its Eli Lilly (LLY) stake by 7.6% in Q1 2026, selling an estimated $3.98M and leaving 47,894 shares worth $44.1M. The position accounts for 3.04% of the portfolio, ranked #11.

Vantage Investment Partners first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $55.7M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Vantage Investment Partners held 47,894 shares of Eli Lilly worth $44.1M as of Q1 2026.
  • Vantage Investment Partners sold 3,921 Eli Lilly shares in Q1 2026, an estimated $3.98M.
  • Eli Lilly made up 3.04% of Vantage Investment Partners's portfolio in Q1 2026, its #11 holding.
  • Vantage Investment Partners first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Vantage Investment Partners's Eli Lilly position peaked at $55.7M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Vantage Investment Partners's 13F filing for Q1 2026, filed 1 May 2026.